Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Bivalirudin manufacturer?Norcuron generic name?What condition primarily benefits from sapropterin therapy?Dabrafenib patent expiration?
See the DrugPatentWatch profile for Erythromycin
Erythromycin is produced by the bacterium Saccharopolyspora erythraea (a soil-dwelling actinobacterium). This organism is used industrially to biosynthesize erythromycin as an antibiotic product. [1]
In Saccharopolyspora erythraea, erythromycin is produced through the organism’s secondary-metabolite biosynthetic pathway, generating the macrolide antibiotic as a natural product. The key point for sourcing is that the producing microorganism is Saccharopolyspora erythraea itself. [1]
Erythromycin has historically been produced by fermentation using Saccharopolyspora erythraea. Alternative manufacturing routes may exist (such as semi-synthetic modification of fermentation-derived intermediates), but the classic biological producing source is Saccharopolyspora erythraea. [1]
When a product or process description says it uses Saccharopolyspora erythraea as the source, it means the antibiotic is biosynthesized during microbial fermentation with this bacterium and then recovered and purified to make erythromycin. [1]
Other Questions About Erythromycin :